Tumor angiogenesis—new drugs on the block

Angiogenesis inhibitors could represent a powerful adjunct to traditional cancer treatments, but the most effective routes for therapeutic intervention remain unclear.

[1]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[2]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[3]  H. Augustin,et al.  Antiangiogenic tumour therapy: will it work? , 1998, Trends in pharmacological sciences.

[4]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.

[5]  R. Weichselbaum,et al.  Combined effects of angiostatin and ionizing radiation in antitumour therapy , 1998, Nature.

[6]  T. L. Moser,et al.  Angiostatin binds ATP synthase on the surface of human endothelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Langer,et al.  Troponin I is present in human cartilage and inhibits angiogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.